Invention Grant
- Patent Title: Compositions and methods for inhibition of the JAK pathway
-
Application No.: US16404481Application Date: 2019-05-06
-
Publication No.: US11667611B2Publication Date: 2023-06-06
- Inventor: Ankush Argade , Arvinder Sran , David Carroll , Jeffrey Clough , Kin Tso , Somasekhar Bhamidipati , Sambaiah Thota , Rajinder Singh , Vanessa Taylor , Hui Li , Esteban Masuda
- Applicant: Rigel Pharmaceuticals, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Rigel Pharmaceuticals, Inc.
- Current Assignee: Rigel Pharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Klarquist Sparkman, LLP
- Main IPC: C07D239/42
- IPC: C07D239/42 ; C07D239/48 ; A61K31/505 ; C07D401/12 ; C07D401/14 ; C07D403/12 ; C07D407/12 ; C07D413/12 ; C07D417/12 ; C07D405/12 ; C07D413/14 ; C07D498/04
Abstract:
The invention encompasses compounds having formula I and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, are therapeutically useful.
Public/Granted literature
- US20190256476A1 COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY Public/Granted day:2019-08-22
Information query
